Voltage-gated sodium channels are critical determinants of nerve and muscle excitability. Although numerous toxins and small molecules target sodium channels, identifying the mechanisms of action is challenging. Here we used gating-pore currents selectively generated in each of the voltage-sensors from the four a-subunit domains (DI-DIV) to monitor the activity of individual voltage-sensors and to investigate the molecular determinants of sodium channel pharmacology. The tarantula toxin huwentoxin-IV (HWTX-IV), which inhibits sodium channel current, exclusively enhanced inward gating-pore currents through the DII voltagesensor. By contrast, the tarantula toxin ProTx-II, which also inhibits sodium channel currents, altered the gating-pore currents in multiple voltage-sensors in a complex manner. Thus, whereas HWTX-IV inhibits central-pore currents by selectively trapping the DII voltage-sensor in the resting configuration, ProTx-II seems to inhibit central-pore currents by differentially altering the configuration of multiple voltage-sensors. The sea anemone toxin anthopleurin B, which impairs open-channel inactivation, exclusively enhanced inward gating-pore currents through the DIV voltage-sensor. This indicates that trapping the DIV voltagesensor in the resting configuration selectively impairs openchannel inactivation. Furthermore, these data indicate that although activation of all four voltage-sensors is not required for central-pore current generation, activation of the DII voltagesensor is crucial. Overall, our data demonstrate that gating-pore currents can determine the mechanism of action for sodium channel gating modifiers with high precision. We propose this approach could be adapted to identify the molecular mechanisms of action for gating modifiers of various voltage-gated ion channels.
Introduction
Voltage-gated sodium channels (VGSCs) are the primary generator of the upstroke of the action potential in electrically excitable cells, and abnormalities in VGSCs contribute to numerous inherited and acquired disorders of excitability (Waxman et al., 2000; George, 2005) . A multitude of animal toxins target sodium channel voltage-sensors (Cestele and Catterall, 2000; Catterall, 2002; Blumenthal and Seibert, 2003) . Many of these agents alter sodium current activity and channel gating with distinct voltage-dependent properties, suggesting that they differentially impact the voltage-sensors of VGSCs. However, it can be difficult to determine the precise mechanism of action of agents that target the gating activity of sodium channels.
VGSCs are complex transmembrane proteins composed of 24 transmembrane segments (Fig. 1A) arranged in four homologous a-subunit domains (DI-DIV), each having six transmembrane segments (S1-S6). The central pore of the channel is formed by the S5-S6 regions of each domain and the voltage-sensors by the S1-S4 regions. The highly charged S4 segments (Fig. 1B) in these complexes are surrounded by aqueous crevices that extend into the membrane from both the extracellular and intracellular surfaces. In the voltage-sensor a relatively short proteinaceous region separates the inner from the outer cavity. Normally ions do not traverse the voltage-sensor; rather, charged residues on the S4 segments (Arg or Lys) are transported from the inner crevice to the outer crevice during gating (Bezanilla, 2008) . However, mutations of these charged S4 residues can induce "gating pores" and "gating-pore currents" (Starace and Bezanilla, 2004; Sokolov et al., 2005; Tombola et al., 2005; Struyk and Cannon, 2007; Tombola et al., 2007) . Importantly, these gating-pore currents are ionic currents that do not flow through the central pore of the channel but rather flow through the modified VGSC voltage-sensors (Fig. 1C) . The gating-pore currents generated by single-charge mutations and carried by cations such as Na 1 and H 1 are #1% of the central-pore current in VGSCs, but in potassium channels, because of their 4-fold symmetry, they can be larger (∼6% of the central-pore current) (Sokolov et al., 2005) . Depending on which charged residues in the S4 segments are mutated, gating-pore currents arise either in the resting or the activated configuration (Sokolov et al., 2007; Sokolov et al., 2008b) (Fig. 1C) . Monitoring gating-pore currents can provide unique insight into the configuration of individual voltage-sensors and how they respond to changes in transmembrane voltage.
We mutated the outer charged residues to induce inward gating-pore currents in the resting configuration. We show that inward gating-pore currents generated by each of the individual voltage-sensors can be measured from channels expressed in a mammalian cell line. We demonstrate that gating-pore currents can be used to precisely identify and monitor the ability of toxins to modulate the activity of the individual voltage-sensors.
Materials and Methods
Toxins. Anthopleurin B (ApB) was recombinantly produced as described by Gallagher and Blumenthal (1992) . ProTx-II and huwentoxin-IV (HWTX-IV) were chemically synthesized as described by Middleton et al. (2002) and Xiao et al. (2008) , respectively.
Plasmids and Construction of Sodium Channel Mutants. The cDNA genes encoding the tetrodotoxin-(TTX) and HWTX-IVsensitive Na v 1.5 (C373Y/R800D/S802E) and auxibiliary subunit b1 were cloned from human and subcloned into the pcDNA3.1 vector (Na v 1.5) and an internal ribosome entry site vector (b1) (Lossin et al., 2002) . All mutations inserted into the sodium channel cDNA gene were constructed using the QuickChange II XL Site-Directed Mutagenesis kit (Agilent Technologies, Santa Clara, CA) according to the manufacturer's instruction. All constructs were sequenced to confirm that the appropriate mutations were made. The TTX-and HWTX-IV-sensitive modified wild-type Na v 1.5 channel is referred to as wild type* (WT*) in this study.
Transient Transfection. Transient transfection of hNa v 1.5 constructs into human embryonic kidney 293 (HEK293) cells was performed using the calcium phosphate precipitation method. HEK293 cells were grown under standard tissue culture conditions (5% CO 2 and 37°C) in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS). All hNa v 1.5 mutant channels were cotransfected with the hb1-subunit to increase current density. The calcium phosphate-DNA mixture (channel constructs and a green fluorescent protein reporter plasmid) was added to the cell culture medium and left for 3-4 hours, after which the cells were washed with fresh medium. Cells with green fluorescent protein fluorescence were selected for whole-cell patch-clamp recordings 36-72 hours after transfection.
Electrophysiological Recordings. Ionic currents were recorded at room temperature (∼21°C) using an EPC-10 amplifier and the PulseFit program (Version 8.31; HEKA, Lambrecht/Pfalz, Germany). Fire-polished electrodes were fabricated from 1.7-mm capillary glass (VWR, West Chester, PA) using a P-97 puller (Sutter Instrument Company, Novato, CA). To minimize capacitive artifacts, the electrode tips were coated with sticky wax (Coltène/Whaledent Inc., Cuyahoga Falls, OH). After filling with the intracellular solution containing (in mM): CsF 140, EGTA 1.1, NaCl 10, and HEPES 10, pH 7.3 (adjusted with HCl), the access resistance of electrode pipettes ranged between 0.9 and 1.8 MV. The intracellular solution for recording outward gating-pore current contained (in mM): CsF 130, guanidine sulfate 10 mM, EGTA 1.1, NaCl 10, and HEPES 10, pH 7.3 (adjusted with HCl). The bathing solution was (in mM): NaCl 140, MgCl 2 1, CaCl 2 3, and HEPES 10, pH 7.3 (adjusted with NaOH). The liquid junction potential for these solutions was ,8 mV; data were not corrected to account for this offset. The offset potential was zeroed before patching. After establishing the whole-cell recording configuration, the cells were held at 2100 mV for 5 minutes. A P/-5 subtraction protocol was used to remove linear leak current and capacitance artifact only for data shown in Figs. 4, A and B, and 6, A and B; no online subtraction was performed in other experiments. Ion currents were filtered at 5 kHz and sampled at 20 kHz. Voltage errors were minimized using 70-80% series resistance compensation.
Toxin stock solutions were made at 100 mM using the bathing solution containing 1 mg/ml bovine serum albumin, and aliquots were stored at 220°C. Before use, the solution was diluted to the concentrations of interest with fresh bathing solution. Toxin was diluted into the recording chamber (volume of 300 ml) and mixed by repeatedly pipetting 30 ml to achieve the specified final concentration.
Data Analysis. Data were analyzed using the software programs PulseFit (HEKA) and GraphPad Prism 5.0 (GraphPad Software, Inc., San Diego, CA). All data are shown as mean 6 S.E. The number of separate experimental cells is presented as n. The "activation threshold" for gating-pore currents (see Figs. 2, 3 , 5, and 7) was defined as the most positive voltage at which gating-pore current can be observed above the baseline noise measured at fully depolarized potentials (i.e., 0 mV), and was judged by eye. Statistical analysis was carried out by Student's t test, and P , 0.05 indicated a significant difference.
Results
Quantification of Sodium Channel Gating-Pore Currents in Mammalian Cells. Our goal was to determine if gating-pore currents could be used to investigate the mechanisms of interaction for toxins that modify VGSCs. Although gating-pore currents have been observed in Xenopus oocytes, they have not previously been recorded from mammalian heterologous expression systems such as HEK293 cells. We used HEK293 cells here because voltage-gated ion channels may be have a greater tendency to undergo normal posttranslational modifications in mammalian cells than in Xenopus oocytes, which could be an advantage in dissecting toxin-channel interactions.
We first determined if we could obtain measureable gatingpore currents from each of the four individual voltage-sensors for a VGSC expressed in a mammalian cell line. To maximize our chances for success, we chose to use human Na v 1.5 VGSCs, which routinely generate large central-pore currents (often up to 50 nA) compared with other VGSCs. For our studies we used a hNa v 1.5 construct that was modified to be sensitive to the pore blocker TTX (Satin et al., 1992) and the gating modifier HWTX-IV (Xiao et al., 2008) . Hereafter this hNa v 1.5-C373Y/R800D/S802E construct will be referred to as WT* to distinguish it from the subsequent gating-pore constructs containing additional mutations. In the WT* construct, 1 mM TTX blocked virtually all of the transient sodium current conducted by the central pore (Supplemental Fig. 1A ). In the presence of TTX, cells expressing WT* channels exhibited only linear leak currents; no gating-pore currents were observed (Supplemental Fig. 1B) . To obtain measureable gating-pore currents from each of the individual voltage-sensors, we made a series of single, double, and triple mutations in each domain where charged residues in the S4 segment (Fig. 1B) were mutated to glycine residues. Although we were unable to reliably measure gating-pore currents in HEK293 cells from channels with single mutations, mutating the first and second arginines in DI and DII to glycine (R1G/ R2G) yielded resolvable gating-pore currents at negative membrane potentials ( Fig. 2A) . To obtain measureable gating-pore currents from DIII and DIV, we found it necessary to mutate three charged residues in the S4 segments (K0G/ R1G/R2G and R0G/R1G/R2G for DIII and DIV, respectively). For each of these constructs, the peak transient central-pore current was blocked by the addition of TTX ( Fig. 2A , right panels). As was recently reported with Na v 1.4 gating-pore currents measured in Xenopus oocytes (Capes et al., 2012) , TTX failed to alter the gating-pore currents in the voltagesensor subdomains of DI, DII, and DIII, but slightly reduced the gating-pore current amplitude of DIV (P , 0.05; Fig. 2B ). This is consistent with the notion that TTX can subtly impact the configuration of the DIV voltage-sensor. By contrast, the gating-pore currents generated in each of the four voltagesensors were substantially inhibited by 1 mM gadolinium (Supplemental Fig. 2) , consistent with previous studies in Xenopus oocytes (Sokolov et al., 2010) . Interestingly, the voltage dependence of steady-state inactivation was altered by charge mutations in DI, DIII, and DIV, but not DII (Fig.  2D ). The amplitude of the gating-pore currents, relative to the peak transient central-pore current generated by the different domains, also differed significantly for the four voltagesensors, with DII and DIV mutations generating the largest relative gating-pore currents (Fig. 2E) .
Gating-Pore Current Analysis Demonstrates that HWTX-IV Selectively Traps DII in the Resting Position. We next asked if gating-pore currents could be used to characterize toxin-channel interactions. Previously we have Effects of Gly mutations of gating-charge residues in four S4 segments on steady-state inactivation. The voltage dependence of steady-state inactivation was estimated using a standard double-pulse protocol. Currents were plotted as a fraction of the maximal peak current. Data points were fitted with a standard Boltzmann equation. (E) Ratio of Igp to the total central-pore current (I Na ). I Na was estimated by the equation: I Na = I -100 /hinf -100 , in which I -100 is the maximal central-pore current when cells were held at -100 mV, and hinf -100 is the fraction of the total sodium channels available at -100 mV on the basis of steady-state inactivation curve as shown in (D). *P , 0.05; # P , 0.01.
Selective Voltage-Sensor Modulation by Biological Toxins used extensive site-directed mutagenesis to show that tarantula toxin HWTX-IV inhibition of central-pore currents critically depends on specific residues in the DII voltagesensor (Xiao et al., 2008; Xiao et al., 2011) , suggesting that HWTX-IV indirectly inhibited central-pore currents by blocking movement of a voltage-sensor, and thus preventing activation of the channel. We examined the effects of HWTX-IV on inward gating-pore currents generated by each of the four voltage-sensors and found that HWTX-IV only significantly altered the gating-pore currents generated in DII (Fig. 3, A  and B) . HWTX-IV substantially enhanced the amplitude of the gating-pore currents in DII and shifted the activation threshold for these inward DII gating-pore currents by more than 50 mV in the depolarizing direction (Fig. 3C) . The modulation of DII gating-pore currents by HWTX-IV was abolished by point mutations in the DII voltage-sensor (D800R/E802S) that also abolish the ability of HWTX-IV to inhibit the transient central-pore currents (Fig. 4) (Xiao et al., 2008) . These data confirm that HWTX-IV specifically interacts with the DII voltage-sensor and provide compelling evidence that HWTX-IV inhibits central pore sodium currents by selectively trapping the DII voltage-sensor in the resting position, preventing channel activation.
Gating-Pore Current Analysis Demonstrates that Anthopleurin B Selectively Traps DIV in the Resting Position. We also examined the effect of the sea anemone toxin anthopleurin B (ApB) on the VGSC gating-pore currents.
ApB substantially enhances VGSC currents by selectively impairing fast inactivation (Benzinger et al., 1998) . We found that ApB significantly enhanced the gating-pore currents generated in DIV (Fig. 5, A and B) , shifting the threshold for activation of the inward gating-pore currents by almost 180 mV (Fig. 5C) , although having no effect on the gating-pore currents generated by DI, DII, and DIII. Because TTX also can impact DIV gating-pore currents, we measured the effect of a saturating concentration of ApB on DIV gating-pore currents in the absence and presence of TTX. The effects of ApB on DIV gating-pore currents were observed in the absence and presence of TTX (Supplemental Fig. 3 ), indicating that whereas TTX can still bind to sodium channels in the presence of ApB, the impact of ApB on DIV gating-pore currents dominates that of TTX. Site-directed mutagenesis previously identified an aspartate residue (corresponding to D1610 in hNa v 1.5) in the extracellular portion of the DIV voltage-sensor that was crucial to ApB's ability to disrupt fast inactivation (Benzinger et al., 1998) . The effects on DIV gating-pore currents were abolished by the D1610R mutation that nearly eliminates the effect of ApB on sodium channel inactivation kinetics (Fig. 6 ). Thus ApB impairs sodium current inactivation by selectively trapping the DIV voltagesensor in the resting position.
ProTx-II Has Unique Interactions with Multiple Sodium Channel Voltage-Sensors. We next examined the effect of the tarantula toxin ProTx-II on VGSC gating-pore currents. Although several studies have investigated the effects of ProTx-II on VGSCs, the details of the interaction remain unclear. ProTx-II can inhibit the central-pore current of multiple VGSC isoforms (Middleton et al., 2002) but is most potent against Na v 1.7 (Schmalhofer et al., 2008) . Several studies have used site-directed mutagenesis to identify specific residues in the DII voltage-sensor that can partially reduce the inhibitory action of ProTx-II (Schmalhofer et al., 2008; Sokolov et al., 2008a) , suggesting that in part ProTx-II inhibition may be attributable to trapping of the DII voltage-sensor in the closed state. However, extensive analyses of sodium channel chimeras have been unable to confirm the role of the DII voltage-sensor as the sole determinant of ProTx-II inhibition of Na v 1.5, suggesting the toxin might interact with VGSCs in a novel manner (Smith et al., 2007) . Paddle chimeras, where the S3-S4 linker of each VGSC domain was transplanted into a potassium channel, indicated that ProTx-II can interact with the voltage-sensors in DI, DII, and DIV (Bosmans et al., 2008) . Previously, we reported that ProTx-II could both inhibit the peak transient pore current of Na v 1.7, in part by interacting with residues in the DII voltage-sensor, and impair inactivation of Na v 1.7 through interactions with residues in DIV (Xiao et al., 2010 ). Here we show that ProTx-II significantly alters the gating-pore currents generated by the DI, DII, and DIV voltage-sensors (Fig. 7) . The impact on the DIV gating-pore currents was relatively minor but significant, which is consistent with our previous study indicating that the impairment of hNa v 1.5 inactivation by ProTx-II is ∼50-fold less potent than the inhibitory effect on central-pore current activation. However, ProTx-II is ∼15-fold more potent at impairing inactivation of hNa v 1.7 than hNa v 1.5 DIV (Xiao et al., 2010) . Therefore, we asked if ProTx-II was able to inhibit hNa v 1.7 DIV gating-pore current to a greater extent than that of hNa v 1.5, and this was indeed what we observed (Supplemental Fig. 4 ).
ProTx-II had mixed effects on DII gating-pore currents, inhibiting them at extreme negative potentials (, -180 mV) but substantially enhancing them between -160 and -10 mV. Surprisingly, ProTx-II substantially inhibited the gating-pore currents through the DI voltage-sensor, suggesting that ProTx-II destabilizes the resting state of this voltage-sensor. To investigate this we created additional mutations in each of the hNa v 1.5 WT* voltage-sensors in an attempt to generate outward gating-pore currents that would flow at depolarized potentials when the voltage-sensors were at activated positions (see schematic diagram in Fig. 1C ). We were unsuccessful in generating outward gating-pore currents through the DIII and DIV voltage-sensors but did obtain them in the DI and DII voltage-sensors after mutating the 3rd and 4th charged residues to glycine (Supplemental Fig. 5 ). These outward gating-pore currents were inhibited by 1 mM gadolinium (Supplemental Fig. 6 ). Both ProTx-II and HWTX-IV substantially blocked the outward gating-pore currents through the DII voltage-sensor (Fig. 8, C and D) . This, in combination with the ability of both toxins to enhance inward gating-pore currents in DII, is consistent with the proposal that these toxins both trap the DII voltage-sensor in the resting configuration. ProTx-II also substantially blocked the outward gating-pore currents generated in DI (Fig. 8A) , shifting the threshold for activation by 150 mV or more. Taken together, these data on ProTx-II effects on inward and outward gating-pore currents indicate that ProTx-II does not trap the DI voltage-sensor in either the resting or activated configuration, but rather locks it in an intermediate state, preventing it from reaching the fully activated configuration. However, because ProTx-II may interact with both the DII and DIV voltage-sensors, which flank the DI voltage-sensor, an alternative possibility was that ProTx-II only indirectly modifies the activity of the DI voltage-sensor. To test this possibility, we examined the effect of simultaneously applying both HWTX-IV and ApB on DI gating-pore currents. In contrast to ProTx-II, coapplication of HWTX-IV and ApB had only a minor inhibitory effect on the outward gating-pore currents in DI (Fig. 8B ) and the inward gating-pore currents generated by the R1G/R2G mutations in DI (Supplemental Fig. 7 ). These data indicate that trapping both the DII and DIV voltage-sensors in the resting state has only a small impact on the movement of the DI voltage-sensor, and thus confirm that ProTx-II most probably blocks sodium channel activation by directly interacting with the DI as well as the DII voltage-sensor.
Discussion
VGSCs are intimately involved in normal and abnormal electrical excitability in a multitude of tissues. Although numerous animal toxins and drugs can alter sodium currents and sodium channel gating, it is difficult to determine how specific agents alter the activity of individual sodium channel voltage-sensors. Here we used gating-pore currents to investigate the impact of three different peptide toxins on each Igp were elicited by the protocol as described in the legend of Supplemental Fig. 3 . Cells were held at -100 mV and pretreated with 1 mM TTX. All currents are normalized to the maximal control current amplitude. Linear leak currents were subtracted.
Selective Voltage-Sensor Modulation by Biological Toxins of the four voltage-sensors. Our data show that 1) inward gating-pore currents, which reflect the resting configuration, can be recorded in HEK293 cells from each of the four voltagesensors, 2) peptide toxins have unique signatures reflecting their interactions with the voltage-sensors, 3) the activity of the individual voltage-sensors are independent, and 4) the DIV voltage-sensor plays a specialized role in channel activity. Overall these data demonstrate that gating-pore currents can be used to identify molecular determinants of sodium channel gating and pharmacology.
Although gating-pore currents have previously been recorded from ion channels expressed in Xenopus oocytes, demonstration of gating-pore current recordings from mammalian cell lines has been lacking. Here we demonstrated that inward gating-pore currents can be recorded from each of the four voltage-sensors following sodium channel expression in HEK293 cells. Outward gating-pore currents could be recorded from DI and DII voltage-sensors. Although the gating-pore currents are smaller in mammalian cell lines and thus more challenging to record, heterologous expression of sodium channels in mammalian cell lines can have advantages. Posttranslational modifications are more probably conserved, and therefore gating and pharmacological properties should better replicate those of sodium channels in primary cells. In addition, mammalian cell lines such as HEK293 cells are more amenable to screening assays. Because gating-pore currents provide a more direct measurement of the conformation changes that individual voltage-sensors undergo, and because they have the potential to substantially alter resting membrane potential and proton flux (Wu et al., 2011) , gating-pore current constructs may eventually be useful in high-throughput fluorescent screening assays for gating modifiers. However, one caveat of the approach is that it requires mutating charged residues in the S4 segments. Although mutating the outer S4 arginine residues in DII did not significantly alter sodium channel inhibition by HWTX-IV (Xiao et al., 2011) or ProTx-II (Sokolov et al., 2008a) , arginine mutations can impact some toxin channel interactions (Bosmans et al., 2008) and this potential influence needs to be considered.
Our data showed that HWTX-IV selectively enhanced inward gating-pore currents generated in the DII voltagesensor. This is consistent with HWTX-IV selectively trapping the DII voltage-sensor in the closed configuration. Although HWTX-IV can fully inhibit central-pore currents, it is interesting to note that HWTX-IV had no effect on the amplitude or voltage-dependence of gating-pore currents generated in the other three voltage-sensors. Thus trapping the DII voltage-sensor in the closed configuration is sufficient to prevent activation. Interestingly, HWTX-IV did not simply shift the voltage-dependence of the DII gating-pore currents but also seemingly enhanced the amplitude at negative potentials. This suggests that even at -200 mV, the voltagesensor in the absence of toxin is not fully locked in the closed position but fluctuates between configurations that do and do not allow the flow of gating-pore currents. One possibility is that HWTX-IV enhances gating-pore current amplitude by stabilizing the voltage-sensor in a position that permits a more consistent flow of ions through the gating pore. Alternative explanations include the possibility that the toxin binding alters the size of the gating pore, thus enhancing ion flow. It is difficult to determine the precise mechanism underlying the increased gating-pore current amplitude on the basis of our data presented here.
ApB selectively enhanced inward gating-pore currents generated in the DIV voltage-sensor. This is consistent with ApB selectively trapping the DIV voltage-sensor in the closed configuration. However, ApB does not inhibit central-pore currents but rather selectively impairs open channel inactivation. Thus, selectively trapping the DIV voltage-sensor in the closed configuration does not prevent the other voltagesensors from shifting to the outward, activated configuration and inducing opening of the channel pore. Taken together these data demonstrate that the activity of the four voltagesensors is essentially independent and that whereas activation of the DII voltage-sensor is crucial for opening the sodium channel central pore, activation of the DIV voltage-sensor is not necessary. This demonstration that the DIV voltagesensor plays a crucial and selective role in open-channel inactivation is at odds with the proposal that inactivation does not have inherent voltage-dependence (Aldrich et al., 1983; Bezanilla and Armstrong, 1977) , but consistent with more recent studies suggesting the DIV voltage-sensor has a unique specialized role in inactivation (Chen et al., 1996; Sheets et al., 1999; Yang and Kuo, 2003; Capes et al., 2013) .
ProTx-II has complex actions on VGSC currents (Edgerton et al., 2008) and the molecular determinants of these actions have been elusive and controversial (Bosmans et al., 2006 (Bosmans et al., , 2008 Smith et al., 2007; Schmalhofer et al., 2008; Sokolov et al., 2008a; Xiao et al., 2010) . Our data show that ProTx-II substantially modulates the conformation of both the DI and DII voltage-sensors in Na v 1.5. Although ProTx-II predominantly enhanced inward gating-pore currents generated in DII, indicating that it favors the resting configuration of this voltage-sensor, it inhibited inward gating-pore currents generated in DI, suggesting that it stabilizes the DI voltagesensors into an intermediate configuration. ProTx-II is considered highly lipophilic and probably inserts into the membrane to interact with VGSCs (Smith et al., 2005) . It is interesting to note that binding studies suggest that there may only be one high-affinity ProTx-II binding site on Na v 1.7 channels (Schmalhofer et al., 2008) . These observations raise the intriguing possibility that a single ProTx-II molecule might simultaneously interact with the DI and DII voltagesensors in a novel manner compared with that of other VGSC gating modifiers. Although the tarantula toxins HWTX-IV Fig. 3 . The subtraction of linear leak currents has been performed. Cells were held at -100 mV and pretreated with 1 mM TTX. All currents are normalized to the maximal control current amplitude. ApB concentration is 100 nM. Note that WT* means the triple C373Y/R800D/S802E mutant Na v 1.5 channel. and ProTx-II can both inhibit sodium channel central-pore currents and interact with the DII voltage-sensor, our gating-pore current data, in conjunction with mutagenesis studies (Bosmans et al., 2008; Schmalhofer et al., 2008; Xiao et al., 2008; Xiao et al., 2010) , indicate that these two peptide toxins have distinct interactions with voltage-gated sodium channels.
Overall, our data demonstrate that gating-pore currents can provide unique insight into the ability of toxins to impact the activity of individual voltage-sensors and help identify the molecular determinants of toxin-channel interactions. The gating-pore current analysis approach that we developed could also be used to explore the mechanism of action of small molecules that target voltage-gated sodium channels. Furthermore, we expect that gating-pore currents could be used to investigate of the molecular pharmacology of other voltagegated ion channels [e.g., transient receptor potential (TRP) channels, calcium channels, potassium channels] as well. Effect of HWTX-IV on DII outward Igp. All currents before (left) and after (right) toxin treatment were elicited by 100-ms depolarizing steps to various potentials that ranged from -100 to +70 mV. No subtraction of linear leak and capacitance currents was performed for current traces. The dotted line across current traces represents the zero current level. Cells were pretreated with 1 mM TTX to completely block the central-pore current and held at -100 mV. Note that in the I-V curves, linear leak currents have been subtracted. *P , 0.05; # , 0.01.
